Caris Initiates Coverage on Spectranetics (SPNC) with an Average
More News related to SPNC
- Spectranetics to Present at the Canaccord Adams 3rd Annual Cardiovascular Conference on November 10
- Trading Radar for 10/28: First Solar (FSLR), ConocoPhillips (COP), WellPoint (WLP), Goodyear (GT), Int. Paper (IP) Report
- Spectranetics (SPNC) Posts Q3 Loss of $0.08
- Spectranetics Reports Third Quarter Revenue Up 7% to $28.8 Million
- Spectranetics to Hold 2009 Third Quarter Financial Results Conference Call on October 28
More News related to New Coverage
- Morgan Stanley Initiates Coverage on Williams Companies (WMB) with an Overweight
- Morgan Stanley Starts ONEOK (OKE) at Underweight, $40 Price Target
- Broadpoint.Amtech Initiates Coverage on Willbros Group (WG) with a Buy; Leading North American Pipeline Contractor
- Miller Tabak Initiates Coverage on Oclaro (OCLR) with a Buy
- Natixis Bleichroeder Initiates Coverage on Gen-Probe (GPRO) with a Buy
Caris initiates coverage on Spectranetics (Nasdaq: SPNC) with an Average. Price target $5.
The Spectranetics Corporation develops, manufactures, markets and distributes single-use medical devices used in minimally invasive procedures within the cardiovascular system for use with Spectranetics' excimer laser system.
Related Categories
New CoverageStocks Mentioned
-0.06Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
